Fintech startups offer banks tools to harness agentic AI
The next wave of artificial intelligence is reimagining business, with fintech startups developing products to ease workflow and back-office processes and helping financial institutions manage compliance and security.
As banks and fintechs are looking to agentic AI to solve pain points or automate their workflows, the latest crop of fintech startups in the Fintech Innovation Lab are working to build those tools.
"Almost all of this year's class, selected by our financial services partners, are using AI to improve internal operations, technology, deployment, data usage, compliance and security," said Maria Gotsch, president of the Partnership Fund for New York City. "They represent the next frontier in New York's fintech sector, which is becoming the epicenter for the application of AI within financial services."
New York has emerged as a global leader in fintech investment, with 30% of investment in 2024 going to firms headquartered in the city. According to research from JPMorgan Chase's workplace solutions unit, New York fintechs snapped up $5.6 billion of the $18.8 billion invested that year. One of the startups showcased in New York, Lyzr, is offering users both pre-built AI agents for banking jobs such as refund management, regulatory monitoring and teller assistance. If one of Lyzr's pre-built agents isn't a good fit for a bank, the fintech offers a platform called Agent Studio for firms to build customized agents on their own without having to write the code. Lyzr also embedded responsibility and hallucination management modules within its core agent-building platform to bolster AI agent effectiveness.
Another featured fintech, AnChain.AI, monitors blockchain and cryptocurrency transactions for potential fraud or money laundering using agentic AI software. Currently used for financial crime investigations by regulatory agencies such as the Financial Crimes Enforcement Network and the Securities and Exchange Commission, AnChain.AI is expanding to the broader financial services market so banks can monitor their own transactions for AML compliance.
The Fintech Innovation Lab is an annual 12-week accelerator program founded and run by Accenture and the Partnership Fund for New York City. This year, BNY's Manhattan office hosted the Fintech Innovation Lab's in-person presentations and demonstrations. The fintechs presented their solutions to investors and executives across the financial services industry as a "graduation" from the program.
"The nature of the kinds of fintech participants in this demo day have kind of evolved over time, and today it's almost uniquely focused on AI and agentic AI," Marianna Lopert-Schaye, global head of Strategic Partnerships, Investments & Innovation at BNY, told American Banker. "It's a core focus of innovation for most of the banking and financial services industry in New York. It's not surprising to me that the selection process has really been looking for who are some of the most innovative, relevant startups in that space."
Accenture, one of the primary sponsors of the accelerator, focused on bringing agentic AI startups into this year's cohort to help banks narrow their focus in searching for AI partners.
"We really believe that, based on our research, generative AI has the potential to transform the financial services industry more than any other industry," said Leo Framil, Accenture's U.S. client lead for financial services. "We are in a very important moment for the industry, and the winners will be the institutions that are able to understand, implement and scale AI innovation."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Investors in IHH Healthcare Berhad (KLSE:IHH) have seen notable returns of 38% over the past five years
When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying the right stocks can give your wealth a significant boost. For example, the IHH Healthcare Berhad (KLSE:IHH) share price is up 28% in the last 5 years, clearly besting the market return of around 6.4% (ignoring dividends). On the other hand, the more recent gains haven't been so impressive, with shareholders gaining just 12%, including dividends. So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Over half a decade, IHH Healthcare Berhad managed to grow its earnings per share at 114% a year. The EPS growth is more impressive than the yearly share price gain of 5% over the same period. So it seems the market isn't so enthusiastic about the stock these days. You can see below how EPS has changed over time (discover the exact values by clicking on the image). Dive deeper into IHH Healthcare Berhad's key metrics by checking this interactive graph of IHH Healthcare Berhad's earnings, revenue and cash flow. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for IHH Healthcare Berhad the TSR over the last 5 years was 38%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! It's good to see that IHH Healthcare Berhad has rewarded shareholders with a total shareholder return of 12% in the last twelve months. That's including the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 7% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. Before forming an opinion on IHH Healthcare Berhad you might want to consider these 3 valuation metrics. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Malaysian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Unplugged Performance to Showcase Tesla Builds at Electrify Expo – North America's Largest EV Festival
3/4 Shot of 2024 Tesla Model 3 Performance with Unplugged Performance Carbon Fiber Aero Kit, UP Forged UP-03 Wheels, and Rear Dual Wing 2024 Tesla Model 3 Performance with Unplugged Performance Carbon Fiber Aero Kit, UP Forged UP-03 Wheels, and Rear Dual Wing 2024 Tesla Model 3 Performance with Unplugged Performance Carbon Fiber Front Aero Kit 2024 Tesla Model 3 Performance with Unplugged Performance Carbon Fiber Front Aero Kit, UP Forged UP-03 Wheels Birdseye view of a Tesla Model 3 Performance Highland with Carbon Fiber Aero Kit and UP Forged UP-03 Wheels Tesla Model Y with Leveling Lift Kit 2026 Tesla Model Y with Leveling Lift Kit and UP Forged UP-05 Wheels 2026 Tesla Model Y with Leveling Lift Kit and UP Forged UP-05 "Off-Road Spec" Wheels 2026 Tesla Model Y with UP Forged CYBRHEX Wheels Tesla Model Y Juniper with 22" UP Forged CYBRHEX Wheels Tesla Cybertruck INVINCIBLE build with 22" UP Forged CYBRHEX LOS ANGELES, June 20, 2025 (GLOBE NEWSWIRE) -- Unplugged Performance, the world leader in Tesla-focused performance upgrades, is headed to Electrify Expo, North America's premier electric vehicle lifestyle event. Taking place this weekend June 21st & 22nd, Electrify Expo invites EV enthusiasts, media, and families for an immersive look at the future of electrification. Unplugged Performance will be displaying four of its latest builds at the show, each with upgrades tailored for parts performance, durability, and everyday driving. Tesla Model 3 Performance 'Red Rocket' Track BuildBuilt to dominate the track and the streets, car features our: UP Race Pro Coilovers with Adaptive Canceller UP Carbon Fiber Front Aero Kit + Rear Dual Spoiler and Wing Set Up + Rear Spats and Diffuser 18x10.9 UP-03 Forged Wheels Yokohama ADVAN A052 295/35R18 Tires Satin Red 2026 Tesla Model Y Off-Road/Street BuildAdventure-ready, this MY build includes our: UP 35mm Leveling Lift Kit Off-Road Spec 18" UP-05 Forged Wheels Off-Road Sway Bar + End Links Yokohama GEOLANDAR Tires UP INVINCIBLE® Cybertruck Street BuildThe ultimate Tesla Cybertruck to take on anything on earth and beyond with: HD Front & Rear Bumpers, Bull Bar, Rock Sliders Carbon Fiber Hood w/ 50' LED Light Bar Side Sail Panel MOLLE Rack System 22' CYBRHEX Forged Wheels Yokohama GEOLANDAR Tires Quicksilver 2026 Tesla Model Y Off-Road/Street BuildReady for the streets, this MY build includes our: 22' UP Forged CYBRHEX Wheels Moderate option Dual Rate Lowering Springs Yokohama Parada Spex-X Tires Learn more about our products at Media Contact:Bryan Benitezpress@ Photos accompanying this announcement are available at: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Scholar Rock (SRRK) Jumps 16.6% After Successful Weight Loss Drug Trial
We recently published a list of These 10 Stocks Boast Double-Digit Gains Amid Boring Market. Scholar Rock Holding Corporation (NASDAQ:SRRK) is one of the best-performing stocks on Thursday. Scholar Rock jumped by 16.6 percent on Wednesday to close at $36.32 apiece as investor sentiment was bolstered by the positive results from the second phase of its weight loss drug trial. In a statement, Scholar Rock Holding Corporation (NASDAQ:SRRK) said the trial, which aims to assess its drug candidate apitegromab's combination with tirzepatide, was generally well tolerated, leading to higher quality weight loss as compared with taking tirzepatide alone. According to Scholar Rock Holding Corporation (NASDAQ:SRRK), apitegromab therapy in combination with tirzepatide resulted in the preservation of 4.2 pounds of lean mass compared with tirzepatide alone. 'While this is an exciting development for our platform, we remain focused on preparing for the launch of apitegromab, and following its potential approval in SMA, we look forward to studying it in a range of neuromuscular diseases with high unmet need,' said Scholar Rock Holding Corporation (NASDAQ:SRRK) President and CEO Akshay Vaishnaw, adding that he was looking forward to exploring its potential in various rare, severe debilitating neuromuscular disorders. A scientist holding a flask of liquid in a laboratory, highlighting the research and discoveries of new treatments. 'We remain on track to file an IND application for SRK-439 in the second half of this year to support the first in human study,' he said. While we acknowledge the potential of SRRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
